Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

61.50 

0.94 1.6%

as of Apr 09 '21

52 Week Range:

33.02 61.74


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 6.64
8.35
8.98
9.23
9.73
10.36
10.88
13.27
16.82
17.19
16.79
growth rate 25.8% 7.5% 2.8% 5.4% 6.5% 5.0% 22.0% 26.8% 2.2% -2.3%
Earnings BIT 16.79
32.88
27.62
19.84
40.70
38.62
37.00
64.92
73.32
54.48
47.22
growth rate 95.8% -16.0% -28.2% 105.1% -5.1% -4.2% 75.5% 13.0% -25.7% -13.3%
Avg.PE 29.24
23.09
30.03
40.82
36.13
36.25
67.89
78.79
72.65
77.88
77.88
growth rate -21.0% 30.1% 35.9% -11.5% 0.3% 87.3% 16.1% -7.8% 7.2% 0.0%
ROA 3.89
5.64
3.42
2.31
3.11
3.12
2.34
2.68
3.08
0.32
-0.58
growth rate 45.0% -39.4% -32.5% 34.6% 0.3% -25.0% 14.5% 14.9% -89.6% -100.0%
ROE 5.48
7.78
5.34
4.21
5.46
5.28
4.17
4.69
5.22
0.58
-1.03
growth rate 42.0% -31.4% -21.2% 29.7% -3.3% -21.0% 12.5% 11.3% -88.9% -100.0%
ROIC 4.79
6.63
3.92
3.63
4.45
4.25
3.61
3.73
4.36
1.05
-0.20
growth rate 38.4% -40.9% -7.4% 22.6% -4.5% -15.1% 3.3% 16.9% -75.9% -100.0%
Cur. Ratio 2.80
3.05
2.21
2.53
2.55
2.32
2.76
2.73
2.45
2.50
2.32
growth rate 8.9% -27.5% 14.5% 0.8% -9.0% 19.0% -1.1% -10.3% 2.0% -7.2%
Quick Ratio 1.11
1.26
0.92
1.09
1.17
0.94
1.20
1.28
1.24
1.17
1.16
growth rate 13.5% -27.0% 18.5% 7.3% -19.7% 27.7% 6.7% -3.1% -5.7% -0.9%
Leverage 1.57
1.25
1.85
1.80
1.72
1.67
1.89
1.64
1.74
1.85
1.74
growth rate -20.4% 48.0% -2.7% -4.4% -2.9% 13.2% -13.2% 6.1% 6.3% -6.0%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 37.40
48.96
62.30
69.73
80.55
78.10
86.43
115.74
149.38
168.53
157.96
growth rate 30.9% 27.3% 11.9% 15.5% -3.1% 10.7% 33.9% 29.1% 12.8% -6.3%
Acct.Payable 43.80
63.00
55.59
29.81
37.98
30.62
34.93
54.02
54.62
49.84
growth rate 43.9% -11.8% -46.4% 27.4% -19.4% 14.1% 54.7% 1.1% -8.8%
Cur.Assets 112.30
133.65
162.00
165.92
192.34
204.00
243.42
316.12
429.83
454.54
429.71
growth rate 19.0% 21.2% 2.4% 15.9% 6.1% 19.3% 29.9% 36.0% 5.8% -5.5%
Total Assets 369.50
447.02
705.31
728.28
747.17
778.73
942.80
1,111.81
1,620.01
1,757.32
1,664.40
growth rate 21.0% 57.8% 3.3% 2.6% 4.2% 21.1% 17.9% 45.7% 8.5% -5.3%
Cash 3.70
10.13
9.72
7.46
7.36
4.18
19.17
32.34
67.36
44.32
56.92
growth rate 173.7% -4.0% -23.3% -1.4% -43.2% 359.0% 68.7% 108.3% -34.2% 28.4%
Inventory 60.60
69.91
84.60
82.38
91.77
106.00
120.70
155.29
197.54
225.70
198.02
growth rate 15.4% 21.0% -2.6% 11.4% 15.5% 13.9% 28.7% 27.2% 14.3% -12.3%
Cur.Liabilities 40.20
43.80
73.00
65.59
75.43
87.91
88.33
115.62
175.34
181.66
185.00
growth rate 8.9% 66.7% -10.2% 15.0% 16.6% 0.5% 30.9% 51.7% 3.6% 1.8%
Liabilities 133.90
89.93
323.73
322.58
311.91
312.63
444.61
435.48
687.24
807.38
705.82
growth rate -32.8% 260.0% -0.4% -3.3% 0.2% 42.2% -2.1% 57.8% 17.5% -12.6%
LT Debt 82.90
30.74
227.57
238.85
214.49
197.59
314.37
259.01
373.15
432.27
347.18
growth rate -62.9% 640.4% 5.0% -10.2% -7.9% 59.1% -17.6% 44.1% 15.8% -19.7%
Equity 235.60
357.09
381.58
405.71
435.26
466.10
498.19
676.33
932.78
949.94
958.58
growth rate 51.6% 6.9% 6.3% 7.3% 7.1% 6.9% 35.8% 37.9% 1.8% 0.9%
Common Shares 36.00
40.00
43.00
43.00
43.00
45.00
45.00
50.00
54.00
56.00
55.00
growth rate 11.1% 7.5% 0.0% 0.0% 4.7% 0.0% 11.1% 8.0% 3.7% -1.8%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 23.60
59.20
64.64
59.51
34.18
50.96
32.84
38.62
63.32
78.17
45.99
growth rate 150.8% 9.2% -8.0% -42.6% 49.1% -35.6% 17.6% 64.0% 23.5% -41.2%
Cash Dividends 0.00 0.00 0.00 0.00
growth rate
Cash From OA 34.80
34.02
46.94
51.37
53.33
69.46
53.60
62.73
86.53
77.81
165.27
growth rate -2.3% 38.0% 9.5% 3.8% 30.3% -22.8% 17.0% 38.0% -10.1% 112.4%
FCF per Share 0.35
-0.14
-0.45
-0.39
0.27
0.62
0.19
0.46
0.44
-0.06
1.74
growth rate -100.0% 0.0% 0.0% 100.0% 129.6% -69.4% 142.1% -4.4% -100.0% 100.0%
Sale Purchase of Stock 95.33
3.76
3.73
8.15
6.67
5.27
143.81
214.63
6.25
growth rate -96.1% -0.7% 118.5% -18.1% -21.0% 2,628.3% 49.2% -97.1%
FCF 10.00
-27.00
-19.00
-10.00
17.00
17.00
19.00
22.00
20.00
-4.00
116.00
growth rate -100.0% 0.0% 0.0% 100.0% 0.0% 11.8% 15.8% -9.1% -100.0% 100.0%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 296.80
359.45
394.29
449.05
509.69
542.15
603.84
727.85
882.75
994.85
963.88
growth rate 21.1% 9.7% 13.9% 13.5% 6.4% 11.4% 20.5% 21.3% 12.7% -3.1%
Op.Income 17.20
23.04
19.71
16.57
40.70
38.62
37.00
64.92
73.32
54.48
47.22
growth rate 34.0% -14.5% -15.9% 145.6% -5.1% -4.2% 75.5% 13.0% -25.7% -13.3%
IBT 16.80
32.88
27.62
19.84
31.57
31.20
25.39
35.88
49.52
2.19
-13.23
growth rate 95.7% -16.0% -28.2% 59.1% -1.2% -18.6% 41.3% 38.0% -95.6% -100.0%
Net Income 12.50
23.04
19.71
16.57
22.97
23.80
20.12
27.52
42.02
5.45
-9.84
growth rate 84.4% -14.5% -15.9% 38.7% 3.6% -15.5% 36.8% 52.7% -87.0% -100.0%
EPS 0.35
0.58
0.46
0.39
0.53
0.53
0.45
0.55
0.78
0.10
-0.18
growth rate 65.7% -20.7% -15.2% 35.9% 0.0% -15.1% 22.2% 41.8% -87.2% -100.0%
Gross Profit 128.50
165.47
181.99
194.37
225.22
235.78
265.03
326.25
394.77
432.37
401.18
growth rate 28.8% 10.0% 6.8% 15.9% 4.7% 12.4% 23.1% 21.0% 9.5% -7.2%
R&D 15.30
21.94
27.80
33.89
36.63
40.81
45.23
51.40
59.53
65.62
57.54
growth rate 43.4% 26.7% 21.9% 8.1% 11.4% 10.8% 13.7% 15.8% 10.2% -12.3%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT -3.41
10.12
3.45
16.29
17.40
growth rate 100.0% -65.9% 372.5% 6.8%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 168.53
164.88
157.47
161.84
157.96
growth rate -2.2% -4.5% 2.8% -2.4%
Acct.Payable 54.62
56.01
44.44
46.63
49.84
growth rate 2.5% -20.7% 4.9% 6.9%
Cur.Assets 454.54
462.51
445.95
434.63
429.71
growth rate 1.8% -3.6% -2.5% -1.1%
Total Assets 1,757.32
1,749.27
1,715.87
1,670.51
1,664.40
growth rate -0.5% -1.9% -2.6% -0.4%
Cash 44.32
50.08
49.70
44.55
56.92
growth rate 13.0% -0.8% -10.4% 27.8%
Inventory 225.70
227.78
221.42
209.11
198.02
growth rate 0.9% -2.8% -5.6% -5.3%
Cur.Liabilities 181.66
165.29
174.22
186.05
185.00
growth rate -9.0% 5.4% 6.8% -0.6%
Liabilities 807.38
809.47
787.02
736.67
705.82
growth rate 0.3% -2.8% -6.4% -4.2%
LT Debt 431.98
442.95
408.23
353.41
347.18
growth rate 2.5% -7.8% -13.4% -1.8%
Equity 949.94
939.80
928.85
933.84
958.58
growth rate -1.1% -1.2% 0.5% 2.7%
Common Shares 55.21
590.07
595.73
600.74
606.22
growth rate 968.7% 1.0% 0.8% 0.9%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 20.83
13.95
11.85
9.79
10.40
growth rate -33.0% -15.0% -17.4% 6.2%
Cash Dividends
growth rate
Cash From OA 26.91
28.86
44.35
55.14
36.92
growth rate 7.3% 53.7% 24.3% -33.1%
Sale Purchase of Stock 6.25
1.26
2.41
1.28
growth rate -79.8% 91.0% -46.7%
FCF 6.08
14.91
32.50
45.35
26.52
growth rate 145.5% 117.9% 39.6% -41.5%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 255.69
243.53
218.37
243.98
258.00
growth rate -4.8% -10.3% 11.7% 5.8%
Op.Income -3.41
10.12
3.45
16.29
17.40
growth rate 100.0% -65.9% 372.5% 6.8%
IBT -7.96
-1.99
-22.30
-2.18
13.25
growth rate 0.0% 0.0% 0.0% 100.0%
Net Income -4.21
-3.15
-19.06
-3.01
15.38
growth rate 0.0% 0.0% 0.0% 100.0%
EPS
growth rate
Gross Profit 111.63
103.78
84.22
102.01
111.16
growth rate -7.0% -18.9% 21.1% 9.0%
R&D 16.25
14.87
14.03
13.51
15.13
growth rate -8.5% -5.7% -3.7% 12.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (44.05)

YOY Growth Grade:

D (35.32)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 77.88 -341.67 27.58
EPS / Growth 15.1% -0.18 11.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.4% 12.7% 12.7%
Future PE 22.78 26.45 26.45
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.